These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9602330)

  • 1. No evidence for c-erbB-2 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
    Histopathology; 1998 Apr; 32(4):335-9. PubMed ID: 9602330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronology of p53 protein accumulation in gastric carcinogenesis.
    Craanen ME; Blok P; Dekker W; Offerhaus GJ; Tytgat GN
    Gut; 1995 Jun; 36(6):848-52. PubMed ID: 7615272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
    J Pathol; 1998 Sep; 186(1):36-40. PubMed ID: 9875138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of cyclin D1 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN
    Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
    Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
    Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of p53 expression in precancerous and malignant gastric mucosa.
    Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
    Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.
    Pimentel-Nunes P; Afonso L; Lopes P; Roncon-Albuquerque R; Gonçalves N; Henrique R; Moreira-Dias L; Leite-Moreira AF; Dinis-Ribeiro M
    Pathol Oncol Res; 2011 Sep; 17(3):677-83. PubMed ID: 21455638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of E-cadherin expression in early gastric cancer.
    Blok P; Craanen ME; Dekker W; Tytgat GN
    Histopathology; 1999 May; 34(5):410-5. PubMed ID: 10231415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prognostic significance of expression of c-met oncogene and its relation to gastric mucosal lesions].
    Zhuang X; Zheng J; Lin S; Sun G; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):409-11. PubMed ID: 11866940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.
    Zheng Y; Wang L; Zhang JP; Yang JY; Zhao ZM; Zhang XY
    World J Gastroenterol; 2010 Jan; 16(3):339-44. PubMed ID: 20082479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of syndecan-1 at different stages in the course of gastric carcinoma and its significance].
    Xi YX; Song X; Chen J; Chen HX; Peng TS; Lin HL; Chen MH
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):193-6. PubMed ID: 17649635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
    Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
    Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CORRELATION BETWEEN C-erbB-2 WITH GASTRIC MUCOSAL ATYPICAL HYPERPLASIA AND GASTRIC CARCINOMA.
    Song B; Yu J; Wu TS
    J Biol Regul Homeost Agents; 2015; 29(2):471-7. PubMed ID: 26122239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of claudin-2 in the multistage process of gastric carcinogenesis.
    Song X; Li X; Tang Y; Chen H; Wong B; Wang J; Chen M
    Histol Histopathol; 2008 Jun; 23(6):673-82. PubMed ID: 18366005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and significance of caudal type transcription factor-2 in gastric mucosa at different stages of gastric carcinogenesis].
    Chen HX; Chen MH; Song X
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):247-9. PubMed ID: 16677504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Sakorafas G; Pavlakis G; Arvanitidis D; Tsianos E; Agnantis NJ
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1674-8. PubMed ID: 16246184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Helicobacter pylori in gastric carcinoma.
    Prabhu SR; Amrapurkar AD; Amrapurkar DN
    Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
    Agoston AT; Odze RD
    Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.
    Xiao ZY; Ru Y; Sun JT; Gao SG; Wang YF; Wang LD; Feng XS
    Asian Pac J Cancer Prev; 2012; 13(1):247-50. PubMed ID: 22502678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.